CASI Pharmaceuticals (CASIF) Interest & Investment Income (2024 - 2025)
CASI Pharmaceuticals' Interest & Investment Income came in at $3,000 for Q4 2025, down 97.7% from $130,000 a year earlier and down 70.0% from the prior quarter.
Powered by 
Analysis
CASI Pharmaceuticals (CASIF) Interest & Investment Income (2024 - 2025) Analysis & Trends
For FY2025, CASI Pharmaceuticals' Interest & Investment Income was $135,000, down 75.0% from FY2024.
- Interest & Investment Income carries a three-year compound annual growth rate of -10.6% (FY2022 to FY2025).
- Going back by year, Interest & Investment Income was $539,000 in FY2024 (-14.3%), $629,000 in FY2023 (+232.8%) and $189,000 in FY2022.
- The Q4 2025 figure represents the lowest quarterly Interest & Investment Income in data going back to Q1 2024.
- Year-over-year, Interest & Investment Income has declined for four consecutive quarters, with an average decline of 74.6% over the last four quarters.
- Business Quant data shows CASIF's Interest & Investment Income at $10,000 (Q3 2025), $45,000 (Q2 2025) and $77,000 (Q1 2025) in the three quarters before Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 219.00 Mn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 80.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | CASI Pharmaceuticals | 2.47 Mn | -18.36 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 3,000.00 |
| Sep 30, 2025 | 10,000.00 |
| Jun 30, 2025 | 45,000.00 |
| Mar 31, 2025 | 77,000.00 |
| Dec 31, 2024 | 130,000.00 |
| Sep 30, 2024 | 143,000.00 |
| Jun 30, 2024 | 135,000.00 |
| Mar 31, 2024 | 131,000.00 |
API Access
CASI Pharmaceuticals Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=CASIF&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "CASIF", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=CASIF&period=max&api_key=YOUR_API_KEY");
const data = await res.json();